Citi Maintains 'Hold' on AmerisourceBergen (ABC), Sees Higher Risk After CVS Acquisition of Longs Drug Stores
More News related to ABC
- AmerisourceBergen (ABC) Declares Dividiend; $500M Buyback
- AmerisourceBergen Increases Dividend 33 Percent and Authorizes a New $500 Million Share Repurchase Program
- Raymond James Upgrades AmerisourceBergen (ABC) to Strong Buy
- PharMerica Reports Results for the Third Quarter 2008 and for the Nine Months Ended September 30, 2008 and Updates Earnings Guidance
- AmerisourceBergen (ABC) Tops Q4 EPS by 2c; Guides In-Line
More News related to CVS
- CVS Caremark Applauds FTC's Leadership on Follow-on Biologics
- Black Friday Shopping Event Starts Early at CVS/pharmacy
- Quarterly Data Confirms Hedge Funds Exited Stocks In A Big Way
- CVS.com Named Best Consumer Health Product Internet Site
- Loeb's Third Point 13F; Shows New Stakes in BUD, C, CVS, MER, WEN, UST, Sells Out of MA
More News related to LDG
- CVS Caremark Successfully Completes Tender Offer for Longs Shares
- CVS Caremark (CVS) Reports Tender Offer for Longs (LDG) at $71.50/Share Has Been Successful
- CVS Caremark Reports Successful Tender Offer for Longs Drug Stores Shares
- CVS Caremark Extends Tender Offer for Longs Drug Stores Shares by One Day
- Notable Mergers and Acquisitions of the Day 10/16: CVS/LDG, BA, ESIO/ZIGO
More News related to Analyst Comments
- Citi Initiates Coverage on US Soft Drink Makers
- William Blair Initiates Coverage on Data Networking Stocks
- Caris Starts Coverage on Ariba (ARBA), Concur (CNQR), salesforce.com (CRM), Taleo (TLEO)
- Oppenheimer Initiates Coverage on ViroPharma (VPHM)
- Oppenheimer Initiates Coverage on Cadence Pharmaceuticals (CADX) with an Outperform
Citi maintains 'Hold' rating on AmerisourceBergen (NYSE: ABC), but moves risk rating from Medium to High. Price target $46.
Citi analyst says, "CVS/Caremark (NYSE: CVS) announced it will acquire Longs Drug Stores (NYSE: LDG) after market close. AmerisourceBergen is the primary drug distributor to Longs Drug Stores that we believe makes up ~$2 billion or 3%-4% of ABC total annual revenues. This is overall unfavorable to AmerisourceBergen as it increases the risk of possible contract loss to CVS’ current retail store distributor and favorable to CVS’ incumbent retail drug dist. CAH that’s up for renewal in mid-2009 where LDG could add ~2% to total company revenue...While this account has not been lost and may remain with ABC, it raises the co’s risk profile with less offsetting diversified businesses to mute any possible negative impact."
AmerisourceBergen Corporation (AmerisourceBergen) is a pharmaceutical services company, with operations in the United States, Canada and the United Kingdom.
Related Categories
Analyst CommentsStocks Mentioned
+2.27
-0.41Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
